TIVA for FESS Surgical Field — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — TIVA eliminates the need for neuromuscular monitoring
TIVA with propofol/remifentanil is preferred for FESS because it produces less surgical field bleeding compared to volatile-based anaesthesia. Propofol causes less vasodilation than volatile agents, and remifentanil provides titratable controlled hypotension, both contributing to a drier surgical field. This improves endoscopic visualisation and surgical precision, reducing complications. The Boezaart grading scale is used to assess surgical field quality. Reduced PONV is a secondary benefit. TIVA does not eliminate the need for neuromuscular monitoring.
Reference: RCOA – 2023 – ENT anaesthesia module; Wormald PJ – 2005 – Surgical field bleeding in FESS